Sphere Medical has 141,757,872 Ordinary Shares of nominal value £0.01 each in issue.


The Wales Life Sciences Investment Fund 25,000,000 17.64%

Woodford Patient Capital Trust Plc 23,125,000 16.31%

LSP Life Sciences Fund 10,904,000 7.69%

Ortho-Clinical Diagnostics 8,141,250 5.74%

Fidelity Worldwide Investments 6,264,649 4.42%

Octopus Investments 6,250,000 4.41%

Ruffer LLP 5,653,895 3.99%

Royal London Asset Management 5,624,185 3.97%

Herald Investment Management 4,711,965 3.32%





Should be an exciting year ahead with developments.
Anybody had a look at this company?

Ah...still no epic....:-(

29 April 2015

Sphere Medical Holding plc

Result of Open Offer

Cambridge, UK, 29 April 2015: Sphere Medical Holding plc (AIM: SPHR.L), ("Sphere Medical" or the "Company") a leading provider of innovative monitoring and diagnostic devices for the critical care setting, announced on 13 April 2015 details of the Company's proposed fundraising through a Placing and Open Offer at 16 pence per share.

The last time and date for receipt of completed application forms and payment in full under the Open Offer was 11.00 a.m. on 28 April 2015. The Company announces that at that time that it had received valid acceptances in respect of 7,352,582 Open Offer Shares from Qualifying Shareholders with a value of some GBP1,176,413. This represents approximately 99% of the 7,425,661 Open Offer Shares offered. As a consequence, the Company has conditionally raised GBP13.2 million (before expenses) through the Placing and Open Offer.

The Placing and Open Offer are all subject to the approval of Shareholders at a General Meeting to be held at 10.00 a.m. on 30 April 2015.

Application has been made to AIM, a market of the London Stock Exchange plc, for the admission of 82,352,582 New Ordinary Shares to be issued pursuant to the Placing and Open Offer. It is expected that Admission will become effective on 1 May 2015. Following Admission, the Company will have 141,757,872 Ordinary Shares in issue.

The New Ordinary Shares, when issued and fully paid will rank equally in all respects with the Existing Ordinary Shares.

Commenting on today's announcement, Dr. Wolfgang Rencken, Chief Executive Officer of Sphere Medical, said:

"We are very appreciative of the continued support from a significant number of our long-term shareholders that have taken part in this Open Offer. The proceeds from the fundraising will further strengthen the Company's balance sheet as we accelerate the commercialisation of Proxima in Europe."

Unless otherwise defined, terms in this announcement shall have the same meanings as those defined in the shareholder circular dated 13 April 2015.

I have today bought a very small holding in this stock. It's not my typical type of play as I prefer stocks with a track record and something I can latch onto.

My rationale is as follows:
1. After a number of years the product is moving to the point of real sales. The market would appear to be huge but it is difficult to quantify how fast sales will increase. I suspect it will be slower than most would like but I am patient.

2. Neil Woodford took up £4m shares at 16p and if 16p is good enough for him I'm happy to take my chances at 16.8p

3. After the placing the shares inevitably fell but I am surprised they have come all the way back to the placing price. I guess someone took up the placing but didn't really want the shares and is selling the placing shares at a profit.

4. There is a daily flow of buys which sooner or later will soak up whoever is selling. Dont' be confused by the trade pattern - all those sells reported at 16.8p are buys.

5. The directors took part in the open offer and put their own money in.

diagnostic devices , have a poor track record, buy after the next loss a/c 12pence ?

16.80p have all been buys as I have added but it was marked down as red....
No issues as I believe this will move quickly when it turns....

RNS...

Sphere Medical confirms that its Annual General Meeting will be held at 11.00am on Thursday, 25 June 2015 at Harston Mill, Harston, Cambridge CB22 7GG. The Notice of Annual General Meeting is set out in the Annual Report and Accounts.

RNS...

Sphere Medical confirms that its Annual General Meeting will be held at 11.00am on Thursday, 25 June 2015 at Harston Mill, Harston, Cambridge CB22 7GG. The Notice of Annual General Meeting is set out in the Annual Report and Accounts.

First Sales and Appointment of New Chairman



Cambridge, UK, 25 June 2015: Sphere Medical Holding plc (AIM: SPHR.L), ("Sphere Medical" or the "Company") a leading provider of innovative monitoring and diagnostic devices for the critical care setting, announces that, at its Annual General Meeting, which will take place at 11:00 am today at Harston Mill, Harston, Cambridge, Dr Anthony Martin, Non-Executive Chairman, will provide the following update:

The two major objectives for Sphere Medical since the beginning of the year have been: the continued commercialisation of Proxima 3 into the UK market and more latterly, into the German, Dutch and Belgium markets; and the finalisation of the development of Proxima 4 alongside Ortho-Clinical Diagnostics as well as fulfilling our obligations under the Collaboration Agreement.

I am pleased to report that the Company has delivered its first commercial order of Proxima 3 product, which represents an important milestone for the Company. Furthermore, we are continuing to grow the number of hospitals showing interest in Proxima 3 and work is continuing with these hospitals for the sale of Proxima into their intensive care settings. The evaluations Sphere has undertaken this year within hospitals have shown that Proxima can reduce the time from ordering a blood gas test to receiving the result by 40% to 60% in a typical clinical environment as well as eliminating the time the nurse is required to spend away from the patient.

Under the terms of the Collaboration Agreement with Ortho-Clinical Diagnostics, Sphere Medical has granted an option to Ortho-Clinical Diagnostics to enter into good faith negotiations for the exclusive rights to commercialise Proxima 4. In connection with this option, Sphere Medical has certain obligations to compile and deliver a data package of reports detailing key product attributes and commercial observations related to Proxima 3 and Proxima 4. Sphere Medical is on schedule to deliver all of these reports.

Work is also on schedule for the submission of the technical and design dossier files necessary for the approval of Proxima 4's CE marks. We currently expect to release these files to our Notified Body during Q3 2015.

On 30 April we announced a successful £13.2 million (gross of costs) fundraise from new and existing shareholders to further strengthen the Company's balance sheet and to enable the achievement of near-term operational and commercial value drivers which we are confident will create substantial value for our shareholders.

On 7 January we announced David Martyr's and Meinhard Schmidt's appointments to the Board as Non-Executive Directors. I indicated at that time that I would be reviewing our succession plan for the Chairmanship of Sphere Medical. I have been Chairman of Sphere Medical for ten years and over that time the Company has developed from a private company engaged in research and development to a commercially-focused public company selling its CE-marked medical device into Europe. I now believe it is time to for me to stand down from my role and therefore I am very pleased to announce that David has agreed to replace me as Chairman. I have every confidence that David's extensive experience within the medical device industry will be of significant benefit to Sphere Medical in the coming years.

WOW!
Big trades gone through today @ 17p......

Trades large enough that we may well get an RNS tomorrow explaining who's been selling and therefore whether the overhang is done or there may be more to go.

CFO leaves legal & gen reduce more money to keep going wanted, 2m at time sold
another holder not a very good picture its a no for me BB willlook again as
previous bb 12p

Woodford just bought another few million shares @ 17p

http://www.moneyam.com/action/news/showArticle?id=5075334

For those that follow Proxima 4 Data Package milestone reached today as planned on time.

SHOC have finally moved off the offer after being there for the last 3-4 weeks. WNTS the only market maker stubbornly sitting there at 19p although you can quite happily buy at 17.6p in reasonable quantity.

I saw that...and on time.
We should hear from OCD quite soon as to weather they wish to negotiate to take up global distributions rights for P4...
Interim results next month....good news hopefully...

Quick update. Price has fallen with rest of general market. Interims on 22nd September where there may or may not be news on sales generation.

More interesting we had 2.8m of buys and sells yesterday which I'm betting is Woodford topping up again. No idea why he keeps topping up but assume he must be assured on it's future. He currently has 18.8% of the shares so this would take it over 20% if it's WPCT fund.

The seller is just as intrigued as there aren't many players with a chunk of shares that large to sell. I'll be glad when whoever it is finished as it appears to be holding the price back. Doesn't really matter though in a way as if Woodford keeps buying eventually the seller will run out.

Look for the RNS as confirmation in the next couple of days

Thanks CC.
But there are quite a few big investors in here and a few didn't take up their recent entitlements in the open offer so the seller could be from any number of holders....
Ortho recently declined to take up the world wide distribution rights which is fair enough as they are under new management and perhaps no longer interested in it.

I do recall Matthew Hall mentioning at the AGM, that there was one or two holders who expressed a willingness to exit as the company no longer met their investment criteria....
But like you, I am intrigued by the recent big trades.....
Hopefully more shall be revealed soon enough....

You may find this useful Ruth. Since I put this together about a month ago Woodford are now at 26,664,500 before yesterday's trades. It requires a little interpretation on some of the smaller holdings as these are only ever reported at particular points in time.
I've never seen an AIM stock like this so tightly held and bit by bit becoming more so.

Woodford RNS out today picking up another 3m shares. Now at 20.9%

Don't know where he got the shares from yet but the "free float" is getting smaller and smaller.

Price picked up a tiny bit today. Would be nice to think it's a permanent rise rather than the MM's taking advantage of PI's after the RNS

Peel Hunt have held close to 1 million shares and perhaps even more after the open offer.
He may have taken their position as they seem more freed up to make a market now...
Still no reflection in the share performance so far....
Have a good weekend...

New Welsh facility opened up........
Contract win in German teaching hospital.
Proxima 4 CE approval under current re view
Update at the end of this month.....full year 2015 results out.
Could be of interest...